Biotech Values

[DewDiligence]

> NFLD's product requires a human blood supply with excess safe blood. If there is a huge problem with the blood supply so there is a shortage of safe blood, NFLD will do real well until their current inventory is gone then they'll be stuck.<

I think croumagnon’s point is that NFLD stands to benefit from the perception of an unsafe blood supply—rather than an actual safety hole that shuts down supply. Such a perception would seem to be a likely outcome of repeated incidents such as the one reported in message #33781.